Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)
China flag China · Delayed Price · Currency is CNY
4.670
-0.050 (-1.06%)
Nov 17, 2026, 3:04 PM CST

SHE:002252 Revenue

Shanghai RAAS Blood Products had revenue of 1.73B CNY in the quarter ending September 30, 2026, a decrease of -18.90%. This brings the company's total for the last twelve months to 6.20B, down -22.03% year-over-year. In the year 2025, Shanghai RAAS Blood Products had annual revenue of 7.35B, down -10.13%. That makes Shanghai RAAS Blood Products the 7,991st largest company in the world by revenue and 1,201st in China.

Revenue (ttm)
6.20B
Revenue Growth
-22.03%
P/S Ratio
5.01
Revenue / Employee
1.53M
Employees
4,045
Market Cap
30.79B

Revenue Chart

Revenue by Geography

  • East China 2.60B 35.4%
  • Northern China 2.09B 28.5%
  • Southern China 1.55B 21.0%
  • Southwest Region 488.64M 6.6%
  • Northwestern Region 304.93M 4.1%
  • Northeast China Region 264.70M 3.6%
  • Export 52.44M 0.7%
Fiscal year ended Dec 31, 2025 See the full SHE:002252 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.35B-828.28M-10.13%
Dec 31, 20248.18B212.50M2.67%
Dec 31, 20237.96B1.40B21.27%
Dec 31, 20226.57B2.28B53.16%
Dec 31, 20214.29B1.53B55.26%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.